NYSE Euronext Balance Sheet | Understand Stock

Ask AI

Overview Financial Statements SEC Filings Executives News Red Flags Capital Raising Ownership Insider Transactions Congressional Trades

Financial Statements

Income Statement Balance Sheet Cashflow Statement

Consolidated Statements of Financial Condition

In millions of USD, except per-share amounts

	Q3 FY2013 As of Sep 30, 2013	Q2 FY2013 As of Jun 30, 2013	Q1 FY2013 As of Mar 31, 2013	Q4 FY2012 As of Dec 31, 2012	Q3 FY2012 As of Sep 30, 2012	Q2 FY2012 As of Jun 30, 2012	Q1 FY2012 As of Mar 31, 2012	Q4 FY2011 As of Dec 31, 2011	Q3 FY2011 As of Sep 30, 2011	Q2 FY2011 As of Jun 30, 2011	Q1 FY2011 As of Mar 31, 2011	Q4 FY2010 As of Dec 31, 2010	Q3 FY2010 As of Sep 30, 2010	Q2 FY2010 As of Jun 30, 2010	Q1 FY2010 As of Mar 31, 2010	Q4 FY2009 As of Dec 31, 2009
Assets
Current assets:
Cash and cash equivalents
Financial investments
Accounts receivable, net
Deferred income taxes
Other current assets
Total current assets
Property and equipment, net
Goodwill
Other intangible assets, net
Deferred income taxes
Other assets
Total assets
Liabilities and equity
Current liabilities:
Accounts payable and accrued expenses
Related party payable
Section 31 fees payable
Deferred revenue
Short term debt
Deferred income taxes
Total current liabilities
Long term debt
Deferred income taxes
Accrued employee benefits
Deferred revenue
Related party payable
Other liabilities
Total liabilities
Redeemable noncontrolling interest
Equity
NYSE Euronext stockholders' equity:
Preferred stock, $0.01 par value per share, 400 shares authorized, none issued
Common stock, 0.01 par value, 800 shares authorized; 278 and 277 shares issued; 244 and 258 shares outstanding
Common stock held in treasury, at cost; 30 and 19 shares
Additional paid-in capital
Retained earnings
Accumulated other comprehensive loss
Total NYSE Euronext stockholders' equity
Noncontrolling interest
Total equity
Total liabilities and equity

Comments